Ginsenoside Rk3

Basic Information

View in Editor

CAS Number

364779-15-7

Molecular Formula

C36H60O8

Molecular Weight

620.86 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Polymers and Plastics Thermoplastics Polyolefins

Laboratory Chemicals Research Chemicals Biochemical Reagents

Basic Physical Properties

Physical State

Powder

Boiling Point

722.4±60.0℃ at 760 mmHg

Solubility

Insuluble (1.2E-3 g/L) (25 ºC),

SMILES

View in Editor

CC(=CCCC(=C)C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C)O)C)C

InChI

InChI=1S/C36H60O8/c1-19(2)10-9-11-20(3)21-12-15-35(7)27(21)22(38)16-25-34(6)14-13-26(39)33(4,5)31(34)23(17-36(25,35)8)43-32-30(42)29(41)28(40)24(18-37)44-32/h10,21-32,37-42H,3,9,11-18H2,1-2,4-8H3/t21-,22-,23+,24-,25-,26+,27+,28-,29+,30-,31+,32-,34-,35-,36-/m1/s1

InChIKey

AVXFIVJSCUOFNT-QXPABTKOSA-N

LogP

4.100800000000007

Topological Polar Surface Area

139.84 Å²

Hydrogen Bond Donor/Acceptor

6 / 8

Complexity

1100

Safety Information

View Safety Information

Storage Conditions

-20℃

Synonyms & References

English

Ginsenoside Rk3 standard
Ginsenoside Rk3
Y0093
3β,6α,12β-Trihydroxydammar-20(21),24-diene-6-O-β-D-glucopyranoside
CS-3848
AS-78397
AKOS030526797
(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-(6-methylhepta-1,5-dien-2-yl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
SCHEMBL18542864
MFCD23379928
Ginsenoside-Rk3
364779-15-7
HY-N0906
AC-34682
CHEBI:228315
CHEMBL4215641

MDL Number

MFCD23379928

FAQ

What regulatory guidelines apply to Ginsenoside Rk3 (CAS: 364779-15-7)?

Ginsenoside Rk3 (CAS: 364779-15-7) is subject to various regulatory guidelines including the Globally Harmonized System (GHS) for classification and labeling of chemicals, REACH regulations in the European Union, and FDA/EPA guidelines in the United States. Manufacturers and handlers must ensure compliance with local health and safety regulations to ensure safe and responsible handling.

Are there alternatives to Ginsenoside Rk3 (CAS: 364779-15-7) in synthesis?

In the synthesis of Ginsenoside Rk3 (CAS: 364779-15-7), alternative reagents such as Ginsenosides Rg3 and Rh2 can be used as substitutes. These analogs and isomers offer similar structural and functional properties, making them viable alternatives in various chemical processes.

What is the market or research trend for Ginsenoside Rk3 (CAS: 364779-15-7)?

The market for Ginsenoside Rk3 (CAS: 364779-15-7) is expanding due to growing interest in natural health products and traditional medicine. Research trends indicate increasing exploration of its pharmacological properties and applications in cancer therapy, cardiovascular health, and immune modulation. The trend also reflects a rising demand for sustainable and effective medicinal compounds.

How should waste containing Ginsenoside Rk3 (CAS: 364779-15-7) be handled?

Waste containing Ginsenoside Rk3 (CAS: 364779-15-7) should be collected and disposed of according to local environmental regulations. Proper incineration or professional waste disposal services are recommended. Handling should be done with caution to prevent environmental contamination, and appropriate personal protective equipment should be used to ensure safety.